Related Experiment Video
Updated: Jun 21, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Effectiveness of antiretroviral therapy in treating paediatric HIV/AIDS in Jamaica
R B Pierre1, J C Steel-Duncan, T Evans-Gilbert
1Department of Obstetrics, Gynaecology and Paediatrics, The University of the West Indies, Kingston, Jamaica.
Insights
Paediatric HIV care in Jamaica improved child survival and quality of life through an effective ambulatory model. This intervention reduced hospitalizations and infections like pneumonia and tuberculosis in children on antiretroviral therapy.
Area of Science:
- Paediatrics
- Infectious Diseases
- Public Health
Background:
- Paediatric HIV/AIDS presents a significant global health challenge, particularly in developing nations.
- Effective management strategies are crucial for improving outcomes in affected children.
Purpose of the Study:
- To evaluate the effectiveness of interventions for children with HIV/AIDS.
- To describe the outcomes of HIV-infected children in ambulatory care settings in Jamaica.
Main Methods:
- Prospective follow-up of 197 HIV-infected children in multicentre ambulatory clinics from 2002 to 2005.
- Data collection on clinical outcomes, antiretroviral therapy (ART) initiation and duration, and anthropometric measurements.
Main Results:
- Low loss to follow-up (6.0%) and mortality rate (4.64 per 100 child-years).
- Significant improvements in weight-for-height and BMI-for-age z scores after 24 months on ART (p=0.001, p=0.002).
- Reductions in hospitalizations (p=0.03) and incidence of pneumonia, sepsis, and tuberculosis in children on ART.
Conclusions:
- A successfully implemented ambulatory model for paediatric HIV care in Jamaica enhances quality of life and survival.
- ART is associated with improved clinical outcomes and reduced opportunistic infections in this cohort.
Background And Purpose:
Paediatric HIV/AIDS remains a significant challenge in developing countries. We describe the effectiveness of interventions in HIV-infected children attending Paediatric Infectious Diseases Clinics in Jamaica.
Methods:
One hundred and ninety-seven HIV-infected children were followed prospectively in multicentre ambulatory clinics between September 1, 2002 and August 31, 2005, in the Kingston Paediatric and Perinatal HIV/AIDS Programme, Jamaica, and their outcomes described.
Results:
Median follow-up was 23 child-months (interquartile range [IQR] 12-31) with 12 children (6.0%) lost to follow-up and deaths (n=13) occurred at 4.64 per 100 child-years of follow-up. Median age was 5.0 years (IQR 2.2-8.1) and 32.1% had Centers for Disease Control and Prevention (CDC) category C disease at enrollment; 62% were ever on antiretroviral therapy (ART) with median duration of 15.4 months (IQR 5.5-25.5); 85% initiated ART with zidovudine/lamivudine/nevirapine. Mean weight-for-height 0.13 +/- 1.02 (mean difference -1.71 [95% Confidence interval (CI) -2.73, -0.69]; p = 0.001) and body mass index-for-age 0.05 +/- 1.11 (mean difference -1.11, [CI -1.79, -0.43]; p = 0.002); z scores increased after 24 months on ART; however, children remained stunted. Reductions in the incidence of hospitalizations (mean diff 30.95, [CI 3.12, 58.78]; p = 0.03) and in episodes of pneumonia, culture-positive sepsis and tuberculosis occurred in those on ART.
Conclusions:
A successfully implemented ambulatory model for paediatric HIV care in Jamaica has improved the quality of life and survival of HIV-infected children.
Related Concept Videos
Retrovirus Life Cycles
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Retroviruses
Antiviral Nucleoside Inhibitors

